These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1780245)

  • 21. [123I-N-isopropyl-p-iodoamphetamine scintigraphy in patients with malignant melanoma].
    Nakabeppu Y; Nakajo M; Iwashita S; Tanoue T; Shinohara S
    Radioisotopes; 1990 Apr; 39(4):163-7. PubMed ID: 2345790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered kinetics of 123I-IMP in irradiated rabbit lungs.
    Suga K; Ariyoshi I; Nakanishi T; Utsumi H; Yamada N
    Nucl Med Commun; 1992 Apr; 13(4):282-9. PubMed ID: 1589181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged lung retention of 123I-IMP in pulmonary fibrosis.
    Ikeda H; Itasaka M; Takahashi K; Komatani A
    Ann Nucl Med; 1992 Aug; 6(3):147-51. PubMed ID: 1389889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the human lung.
    Tanaka E; Mishima M; Kawakami K; Sakai N; Sugiura N; Taniguchi T; Kuno K
    Eur J Nucl Med; 1993 Apr; 20(4):293-6. PubMed ID: 8387920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-isopropyl-p[123I]iodoamphetamine, a new agent for lung imaging studies.
    Van Zandwijk N; Zwijnenburg A; Hoefnagel CA; Marcuse HR
    Thorax; 1986 Oct; 41(10):801-3. PubMed ID: 3787512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differentiation of infiltrates between lung cancer and noncancerous lung disease by 123I-IMP lung imaging].
    Nakajo M; Nakabeppu Y; Iwashita S; Tanoue T; Taguchi M; Shinohara S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):164-71. PubMed ID: 2362796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodistribution of N-isopropyl-p-iodoamphetamine in mice.
    Hoshi H; Jinnouchi S; Watanabe K; Ueda T; Kinoshita K; Yamaguchi T; Tahara Y
    Int J Rad Appl Instrum B; 1988; 15(2):127-31. PubMed ID: 3366615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production.
    Holman BL; Wick MM; Kaplan ML; Hill TC; Lee RG; Wu JL; Lin TH
    J Nucl Med; 1984 Mar; 25(3):315-9. PubMed ID: 6699722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the lung uptake of 123I-IMP by bronchoalveolar lavage].
    Kosuda S; Kawahara S; Tamura K; Kubo A; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Apr; 49(4):484-6. PubMed ID: 2798050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [123I-IMP clearance of the lung with diffuse lung disease].
    Takahashi T; Kato K; Yanagisawa T; Maiya N; Tamura M
    Kaku Igaku; 1991 Feb; 28(2):191-5. PubMed ID: 2051655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine.
    Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Furukawa T; Muranaka A; Yanagimoto S; Tomomitsu T; Tabuchi A
    J Nucl Med; 1988 Aug; 29(8):1448-50. PubMed ID: 3404259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of lung scintigraphy using N-isopropyl-p-[123I]-iodoamphetamine].
    Shabana M
    Kaku Igaku; 1989 Apr; 26(4):515-22. PubMed ID: 2770041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of smoking on dynamics of N-isopropyl I-123 P-iodoamphetamine (I-123IMP) in the lung].
    Matsuse T; Fukuchi Y; Ishida K; Yamaoka M; Nagase T; Kosaka N; Momose T; Watanabe T; Ohtake T; Iio M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jun; 26(6):653-7. PubMed ID: 3241504
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pulmonary inhalation scintigraphy using N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) aerosol].
    Kosuda S; Kawahara S; Ishibashi A; Tamura K; Kubo A; Hashimoto S
    Kaku Igaku; 1991 Jun; 28(6):577-83. PubMed ID: 1895554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin uptake in cerebral cortex cultures: imipramine-like inhibition by N-isopropyl-p-iodoamphetamine.
    de Jong BM; Feenstra MG; Ruijter JM; van Royen EA
    Exp Neurol; 1989 Mar; 103(3):297-9. PubMed ID: 2920796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study on the intrapulmonary kinetics of N-isopropyl-p-[I-123]-iodoamphetamine in patients with interstitial lung diseases--assessment of disease activity by dynamic scintigraphy and regional clearance curve].
    Kumazaki S
    Kaku Igaku; 1989 Nov; 26(11):1417-28. PubMed ID: 2615028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of age on N-isopropyl-p-[123I]iodoamphetamine accumulation in the human heart.
    Nakajo M; Nakabeppu Y; Iwashita S; Shinohara S
    Ann Nucl Med; 1990 Jul; 4(2):49-54. PubMed ID: 2223378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in biodistribution of 11C-methamphetamine (MAP), 14C-MAP, and 123I-N-isopropyl-iodoamphetamine (IMP) in MAP- and cocaine-sensitized animals.
    Numachi Y; Yoshida S; Inosaka T; Sato M; Mizugaki M; Kimura K; Hishinuma T
    Ann N Y Acad Sci; 1992 Jun; 654():153-9. PubMed ID: 1632580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution of radioiodine-labeled N-isopropyl-p-iodoamphetamine in permanently ischemic brain of the Mongolian gerbil.
    Jinnouchi S; Hoshi H; Watanabe K; Ueda T; Yamaguchi T
    Nuklearmedizin; 1988 Feb; 27(1):5-7. PubMed ID: 3368336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New design of N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) lung imaging in the patient with lung cancer.
    Tanaka E; Mishima M; Kawakami K; Sakai N; Sugiura N; Taniguchi T; Ohi M; Itoh H; Kuno K
    Ann Nucl Med; 1995 Nov; 9(4):209-13. PubMed ID: 8770288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.